What is phage display, and how does it support antibody and ligand discovery?

Phage display is a molecular selection strategy in which diverse peptide or protein sequences are presented on the surface of bacteriophage particles, while their corresponding genetic information resides within. This creates a direct genotype-phenotype linkage, enabling iterative enrichment of high-affinity binders through in vitro selection. By employing a target-driven selection process, high-throughput identification of ligands—including antibodies, peptides, or protein scaffolds—with optimal specificity and affinity becomes feasible.

Why choose phage display over conventional antibody discovery methods?

Unlike hybridoma-based technologies, which are limited by host species and throughput, phage display enables comprehensive interrogation of the antibody repertoire from nearly any immunized or naïve host. This allows us to recover antibodies not only from common models such as mice and rabbits, but also from species like camelids, sharks, or even humans. Furthermore, phage display facilitates selection strategies incorporating both positive and negative pressure, thereby enhancing the functional relevance of binders and reducing downstream screening burden.

What are the differences between M13, T4, and T7 phage display systems?

Each phage platform offers unique advantages. M13 is a non-lytic filamentous phage widely used for displaying antibody fragments and small peptides, particularly on pIII or pVIII coat proteins. T4 phage, with its large capsid and double-stranded DNA genome, supports dual-domain display on HOC and SOC proteins, accommodating larger inserts. T7 phage, being lytic and cytoplasmically assembled, offers high expression levels and tolerance for structurally complex or toxic proteins. We advise selection of the system based on target complexity and library design requirements.

Can M13 be used for constructing cDNA libraries?

Due to the constraints of in-frame fusion and secretion requirements intrinsic to M13 phage, it is generally not well suited for direct cDNA expression. Improper reading frames and premature stop codons significantly reduce productive display rates. For cDNA library construction, alternative systems such as T7 or lambda phage are recommended, where display is not limited by secretion or reading frame restrictions.

What is the typical diversity and size of your phage display libraries?

Our custom libraries routinely exceed 10⁸ unique variants, with diversity scaling as high as 1010 when required. Library quality is confirmed by next-generation sequencing and random clone analysis. The absence of recurring sequences among sampled clones strongly indicates robust diversity and minimal clonal dominance.

How do you validate the quality and utility of constructed libraries?

We employ a combination of molecular QC and functional validation steps. Diversity is assessed by sequencing a statistically representative number of clones. Functional testing—such as panning against a test antigen—is used to confirm the enrichment dynamics and selection fidelity. This dual approach ensures that the constructed library is both genetically diverse and capable of yielding biologically relevant binders.

What media and selection conditions do you recommend for maintaining phage libraries?

Media such as 2YT or TSB, supplemented with appropriate antibiotics (e.g., ampicillin and kanamycin), are used to ensure selective growth of infected host strains. The specific formulation depends on the vector system and host strain used. Our protocols are fully optimized and supplied with each custom project to facilitate reproducibility in client laboratories.

Phage Display Library Construction Services

Introduction Library Types Binder Types Workflow Cases Phage Types Phage Display Format Features FAQs Resources

Introduction to Phage Display Library Construction

At Creative Biolabs, we harness phage display technology to engineer antibody libraries, peptide libraries and protein libraries that redefine the boundaries of target engagement. Our platform integrates advanced library construction methodologies with functional validation, enabling rapid discovery of high-affinity binders against diverse antigen classes—from soluble proteins and membrane-bound receptors to post-translationally modified epitopes.

Start your phage display project today. Contact us now.

Creative Biolabs has long been at the forefront of phage display technology. With over two decades of experience, our team provides fully customized phage display library construction services. Central to our approach is the development of libraries exceeding 10¹¹ unique clones, a diversity threshold critical for isolating rare, high-potency binders. We specialize in constructing immune, naïve, and synthetic libraries in scFv, Fab, and sdAb formats, each tailored to specific therapeutic objectives.

Fig.1 Phage display library construction and screening.

Types of Library We Offer

Premade Antibody Library Construction Service

Fig.2 Many gene fragments. (Creative Biolabs AI)

Quick Access

-High-quality, pre-validated libraries for rapid discovery

-Diverse clones from various species (human, mouse, camelids, etc.)

-Reliable and consistent results with minimal setup time

Immune Antibody Library Construction Service

Fig.3 Genes made up of base pairs. (Creative Biolabs AI)

High Affinity

-Antibodies with high affinity due to immune response from immunized animals

-Reduced need for in vitro affinity maturation

-Libraries designed for specific targets and disease relevance

-Larger capacity and diversity compared to naïve libraries

Synthetic and Semi-synthetic Library Construction Service

Fig.4 Double helix DNA. (Creative Biolabs AI)

Vast Diversity

-Vast diversity with fully customizable sequences

-Ability to target complex or rare antigens

-Enables precise control over antibody characteristics (e.g., affinity, specificity)

-Ideal for applications requiring highly specific, tailored antibody candidates

Types of Binder We Offer

Antibody Library Construction Service

ScFv (Single-Chain Variable Fragment) Library Construction Service

Fig.5 Single-Chain Variable Fragment. (Creative Biolabs Original)

-Covalently linked VH and VL domains (25–30 kDa) with flexible peptide spacers, enabling monovalent antigen engagement while retaining compactness.

-Eliminates light-chain pairing variability inherent in traditional antibodies.

-Exceptional thermostability (ΔTm ≥10°C vs full-length IgG) and protease resistance, validated in acidic tumor microenvironments and inflammatory disease models.

-Accelerates discovery of tumor-targeting agents and bispecific antibody precursors with minimized off-target aggregation risks.

Fab (Fragment Antigen-Binding) Library Construction Service

Fig.6 Fragment Antigen-Binding. (Creative Biolabs Original)

-Preserves VH-VL heterodimerization through interchain disulfide bonds, mirroring the antigen-binding topology of intact IgGs.

-Superior for conformation-dependent epitopes requiring precise spatial alignment (e.g., GPCR allosteric pockets, ion channel gating domains).

-Achieves sub-nanomolar affinity (KD ≤0.5 nM) against membrane proteins through mammalian display compatibility.

-Generates therapeutic leads for neurological disorders and autoimmune diseases, where epitope conformational fidelity dictates efficacy.

sdAb (Single Domain Antibody) Library Construction Service

Fig.7 Single Domain Antibody. (Creative Biolabs Original)

-Heavy-chain-only antibodies with solvent-exposed CDR3 loops (up to 24 residues), stabilized by conserved CysCDR1-CysCDR3 disulfide bonds.

-Targets concave or cryptic epitopes (e.g., viral fusion machinery, enzyme catalytic clefts) inaccessible to conventional antibodies.

-Sub-15 kDa size enables blood-brain barrier penetration and intracellular target engagement, with picomolar affinity (KD ≤100 pM) against low-immunogenicity antigens.

-Powers development of inhaled biologics, CAR-T extracellular domains, and viral neutralization agents resistant to escape mutations.

Protein Library Construction Services

Protein Variant Library Construction Service

-Accelerating protein optimization through systematic exploration of functional mutations.

-Enables tailored engineering of therapeutic proteins, enzymes, and antibodies with enhanced stability and activity.

-High-diversity platforms supporting both academic research and industrial biomanufacturing.

Fig.8 Protein microstructure. (Creative Biolabs Original).

Scaffold Library Construction Service

- Non-antibody protein frameworks for novel binding interfaces.

- Ideal for targeting intracellular epitopes and designing cell therapy components (e.g., CAR-T extracellular domains).

- Combines structural stability with modular adaptability across diverse biomedical applications.

Fig.9 The microscopic structure of proteins. (Creative Biolabs Original).

Peptide Library Construction Service

Subtype	Features	Technical Differentiation	Application Value
Linear	8-20 mers / Native frequency simulation	Solid-phase synthesis	Linear epitope mapping
Cyclic	Disulfide cyclization / Rigid conformation constraint	Oxidative folding optimization	Enhanced membrane permeability / GPCR ligand discovery
Mimotope	PTM mimics (phosphorylation/glycosylation)	Non-natural amino acid insertion	Anti-PTM antibody development
Constrained	Backbone crosslinking	Click chemistry cyclization	Protease resistance / Oral delivery
Random	Unbiased diversity (1e12)	Degenerate codon design	De novo bioactive peptide discovery

cDNA Library and Genome Library Construction Services

cDNA Library Construction Service

-Constructed from polyadenylated mRNA via reverse transcription, preserving native splicing patterns and temporal/spatial expression profiles.

-Captures the functional proteome by excluding non-coding genomic regions, enabling direct interrogation of translated gene products.

-Supports yeast two-hybrid screens and phage display for de novo identification of RNA-binding proteins or disease-associated isoform interactions.

-Accelerates therapeutic target discovery in oncology (e.g., oncogenic fusion proteins) and autoimmune disorders (e.g., alternative splicing-derived autoantigens).

Lambda Phage-based Genome Library Construction Service

Fig.11 The genome. (Creative Biolabs AI)

-Encodes 15–20 kb genomic fragments spanning coding/non-coding regions, prepared via mechanical shearing or restriction enzyme digestion.

-Maintains chromosomal context for studying distal regulatory elements (enhancers, insulators) and structural variations (CNVs, translocations).

-Compatible with functional complementation assays and epigenetic modifier screens to dissect cis-regulatory networks.

-Resolves mechanisms of chromosomal instability in cancer and identifies non-coding drivers of developmental disorders.

Choose your library needs with our experts.

Process & Deliverables

(1)Project Consultation

Project Consultation
(2)Repertoire Acquisition

Sourcing the genetic material from either PBMC cells, splenocytes, or synthetic DNA.
(3)Library Construction
- Design & Customization: Tailor libraries based on your specific research needs.
- Gene Synthesis and Library Construction: High-quality synthesis and amplification of phage libraries.
(4)Deliverables
- Diverse, High-Quality Library Kit: Custom-built libraries designed with optimized diversity and specificity to suit your research needs.
- Comprehensive Reports: Detailed documentation and analysis of library quality control (QC) results.

Begin your custom library construction. Request a consultation.

Case-Driven Discoveries: The Power of Our Services

QC Sample for Premade sdAb Antibody Library Construction

Creative Biolabs generated our Camel Naïve sdAb Library, a cutting-edge resource sourced from 15+ individual camels. Designed to elevate your antibody research, this library offers a diverse and robust repertoire of single-domain antibodies (sdAb) for various applications.
Rigorous Quality Control (QC)

Clone Validation: Small-scale clone validation to estimate whether the library meets the standard quality requirements.
Next-Generation Sequencing (NGS): Utilize NGS to perform a detailed analysis of the total library, confirming accuracy and diversity, ensuring a well-balanced and high-quality library.
Potential for Binder Development: The library undergoes screening for common targets to assess its potential for identifying high-affinity binders across a wide range of applications.

Library Capacity >2.0×10¹⁰
Fig.12 Phage display library construction process. (Creative Biolabs Original).

QC by Sanger Sequencing
Sequencing Success Rate 100% Library Accuracy >95% All unique clones
Fig.13 Graph illustrating the library capacity of the CasdAb L-6 library. (Creative Biolabs Original).

Fig.13 Graph illustrating the library capacity of the CasdAb L-6 library. (Creative Biolabs Original).

QC by NGS Sequencing >80% Unique Sequences
Sequence diversity and in-frame of the library qualified by NGS.

Boost your discovery with our services. Contact us now.

Selecting the Right Phage Type

When it comes to phage display, one system definitely doesn't fit all projects. Depending on the target and the intended application—be it therapeutic, diagnostic, or purely exploratory research - the type of phage display system used can make a big difference. Creative Biolabs provides a diverse portfolio of phage display platforms, each optimized to address distinct project requirements. The principal system types are summarized below.

M13 Phage Library Construction Service This is one of the most commonly used systems for displaying peptides and antibody fragments like scFv, Fab, or sdAb. The M13 filamentous phage offers excellent stability and ease of manipulation, making it perfect for many applications.
T7 Phage Library Construction Service Unlike M13, the T7 phage is lytic, which means it replicates more quickly and offers a higher display level. It's great for displaying larger proteins or for situations where rapid amplification is needed.	T4 Phage Library Construction Service This system is less commonly used but can be advantageous when working with specific protein conformations or larger proteins due to its more complex capsid structure.

Partner with us to build your phage display library.

Choosing the Optimal Phage Display Format

As a leading expert in phage display technologies, Creative Biolabs recognizes that the success of a phage display campaign hinges on the careful selection of an appropriate display format. Each filamentous phage coat protein presents distinct structural and functional properties, which can be strategically leveraged depending on the molecular characteristics of the ligand and the intended downstream application.

Coat Protein	Display Capacity	Optimal for	Remarks
pIII	Low copy number (≤5 per virion)	Antibody fragments (scFv, Fab, sdAb), peptides	Enables monovalent display; widely used due to minimal impact on infectivity
pVIII	High copy number (up to ~200 copies)	Small peptides, epitope mapping, polyvalent antigens	Best suited for high-density peptide display; less tolerant to larger inserts
pVI	Moderate display potential	cDNA libraries, large proteins	Allows flexible fusion at N-/C-termini; useful for expression studies
pVII	Low copy number	Antibody fragments, nanobodies	Emerging platform for small scaffold display and post-panning analyses
pIX	Very low copy number (≤5 per virion)	High-affinity ligand selection (monovalent display)	Favours stringent binder enrichment; expression efficiency varies by system

Kickstart your phage display project. Contact us today.

Why Choose Creative Biolabs?

Comprehensive Library Formats

We offer a broad spectrum of phage display library formats, including scFv, Fab, and sdAb-based antibody libraries, as well as peptide, scaffold, and full-length cDNA libraries. This diversity allows us to support a wide range of applications—from therapeutic antibody discovery to functional protein screening.

Customizable Diversity and Design

Our fully synthetic and semi-synthetic libraries are engineered with controlled diversity using hard randomization, tailored codon strategies, and trimer phosphoramidite technology. Libraries can achieve diversity exceeding 1010 variants, with optimizations for stability, affinity maturation, and reduced immunogenicity.

Versatile Display Systems

We tailor phage display platforms—including M13, T4, T7, and lambda phage—to align with the molecular weight, structure, and biological context of the target protein. This flexibility ensures optimal expression and display fidelity across different project goals.

High-Quality Repertoire Sourcing

Our antibody libraries are derived from diverse sources, including immune and naïve human or animal plasma cells and splenocytes. For synthetic designs, we employ sequence-guided frameworks that reflect natural repertoires, enhancing developability and clinical translation.

End-to-End Customization and Support

We provide fully integrated services—from early-stage antigen design to downstream functional validation. Our scientific team works closely with clients to adapt the library design, phage system, and screening strategy to meet specific therapeutic, diagnostic, or research objectives.

Superior Library Capacity and Fidelity

Our phage display libraries are constructed with precise orientation, high insert integrity, and optimized expression, enabling high signal-to-noise ratios during screening. This is particularly advantageous for rare target discovery and low-abundance antigen screening.

Contact us to start your project.

FAQs

Q: What is phage display, and how does it support antibody and ligand discovery?
A: Phage display is a molecular selection strategy in which diverse peptide or protein sequences are presented on the surface of bacteriophage particles, while their corresponding genetic information resides within. This creates a direct genotype-phenotype linkage, enabling iterative enrichment of high-affinity binders through in vitro selection. By employing a target-driven selection process, high-throughput identification of ligands—including antibodies, peptides, or protein scaffolds—with optimal specificity and affinity becomes feasible.
Q: Why choose phage display over conventional antibody discovery methods?
A: Unlike hybridoma-based technologies, which are limited by host species and throughput, phage display enables comprehensive interrogation of the antibody repertoire from nearly any immunized or naïve host. This allows us to recover antibodies not only from common models such as mice and rabbits, but also from species like camelids, sharks, or even humans. Furthermore, phage display facilitates selection strategies incorporating both positive and negative pressure, thereby enhancing the functional relevance of binders and reducing downstream screening burden.
Q: What are the differences between M13, T4, and T7 phage display systems?
A: Each phage platform offers unique advantages. M13 is a non-lytic filamentous phage widely used for displaying antibody fragments and small peptides, particularly on pIII or pVIII coat proteins. T4 phage, with its large capsid and double-stranded DNA genome, supports dual-domain display on HOC and SOC proteins, accommodating larger inserts. T7 phage, being lytic and cytoplasmically assembled, offers high expression levels and tolerance for structurally complex or toxic proteins. We advise selection of the system based on target complexity and library design requirements.
Q: Can M13 be used for constructing cDNA libraries?
A: Due to the constraints of in-frame fusion and secretion requirements intrinsic to M13 phage, it is generally not well suited for direct cDNA expression. Improper reading frames and premature stop codons significantly reduce productive display rates. For cDNA library construction, alternative systems such as T7 or lambda phage are recommended, where display is not limited by secretion or reading frame restrictions.
Q: What is the typical diversity and size of your phage display libraries?
A: Our custom libraries routinely exceed 10⁸ unique variants, with diversity scaling as high as 1010 when required. Library quality is confirmed by next-generation sequencing and random clone analysis. The absence of recurring sequences among sampled clones strongly indicates robust diversity and minimal clonal dominance.
Q: How do you validate the quality and utility of constructed libraries?
A: We employ a combination of molecular QC and functional validation steps. Diversity is assessed by sequencing a statistically representative number of clones. Functional testing—such as panning against a test antigen—is used to confirm the enrichment dynamics and selection fidelity. This dual approach ensures that the constructed library is both genetically diverse and capable of yielding biologically relevant binders.
Q: What media and selection conditions do you recommend for maintaining phage libraries?
A: Media such as 2YT or TSB, supplemented with appropriate antibiotics (e.g., ampicillin and kanamycin), are used to ensure selective growth of infected host strains. The specific formulation depends on the vector system and host strain used. Our protocols are fully optimized and supplied with each custom project to facilitate reproducibility in client laboratories.